1. Home
  2. REX vs EMBC Comparison

REX vs EMBC Comparison

Compare REX & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo REX American Resources Corporation

REX

REX American Resources Corporation

HOLD

Current Price

$34.69

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$12.14

Market Cap

755.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REX
EMBC
Founded
1980
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
755.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
REX
EMBC
Price
$34.69
$12.14
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$25.00
$18.50
AVG Volume (30 Days)
157.7K
447.3K
Earning Date
12-04-2025
02-05-2026
Dividend Yield
N/A
4.97%
EPS Growth
N/A
20.90
EPS
1.48
1.62
Revenue
$650,756,000.00
$1,080,400,000.00
Revenue This Year
$3.27
$2.00
Revenue Next Year
$17.11
$0.27
P/E Ratio
$23.29
$7.46
Revenue Growth
N/A
N/A
52 Week Low
$16.73
$9.20
52 Week High
$36.50
$19.67

Technical Indicators

Market Signals
Indicator
REX
EMBC
Relative Strength Index (RSI) 61.13 45.21
Support Level $33.02 $12.01
Resistance Level $35.22 $13.03
Average True Range (ATR) 1.00 0.45
MACD 0.20 0.01
Stochastic Oscillator 85.73 46.06

Price Performance

Historical Comparison
REX
EMBC

About REX REX American Resources Corporation

REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: